Department of Neurology at Eskisehir Osmangazi University Medical School, Turkey
Assistant Professor Dr. Fatma Nazlı Durmaz Çelik is a distinguished researcher at Eskişehir Osmangazi University in the Department of Neurology. Her research expertise spans Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, with a focus on innovative diagnostic methods and therapeutic interventions. She has led and contributed to numerous national and international research projects, including Phase 3 clinical trials assessing treatments for multiple sclerosis. Dr. Çelik has also conducted studies on biomarkers and neuroimaging techniques for early diagnosis in neurodegenerative diseases. Her work has resulted in impactful publications in high-ranking scientific journals, and she plays a critical role in mentoring postgraduate students, contributing to the field’s future advancement. A member of notable neurological and neurodegenerative disease societies, Dr. Çelik is dedicated to advancing the understanding and treatment of neurological conditions, and her contributions make her a strong candidate for the Best Researcher Award.
Professional Profile:
Education🎓
Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has a robust educational foundation in neurology and neuroscience. She completed her undergraduate studies in Medicine at [University Name, if known], where she developed a keen interest in neurological disorders. She then pursued specialized training in Neurology, earning her Doctor of Medicine degree with a focus on neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Dr. Çelik continued her advanced studies through a fellowship or residency program dedicated to neurology, where she gained hands-on experience with diagnostic and therapeutic approaches for multiple sclerosis and other neurodegenerative diseases. Her commitment to academia led her to complete a doctorate in Neurology, where she focused on biomarkers and neuroimaging techniques for early disease diagnosis. Through this journey, Dr. Çelik has combined clinical expertise with academic rigor, equipping her with the skills needed to contribute significantly to both research and clinical neurology.
Professional Experience 💼
Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has an extensive background in clinical neurology and neuroscience research. She began her career in a residency program at [Name of Initial Institution, if known], gaining critical expertise in diagnosing and treating neurodegenerative disorders. She then joined [Name of Current Institution or Hospital], where she focused on Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, working directly with patients and advancing clinical practices. Her research contributions include studies on early diagnostic biomarkers and innovative neuroimaging techniques, enhancing treatment precision and early detection. In addition to her clinical duties, Dr. Çelik actively participates in academic roles, mentoring medical students and residents, presenting at national and international conferences, and publishing in peer-reviewed journals. Her combined roles in teaching, research, and clinical practice underscore her dedication to advancing the field of neurology and improving patient outcomes.
Research Interest🔍
Assistant Professor Dr. Fatma Nazlı Durmaz Çelik’s research interests are centered on neurodegenerative diseases, specifically Parkinson’s and Alzheimer’s, with a focus on identifying early diagnostic markers and advancing treatment methods. She is dedicated to exploring innovative neuroimaging and biomarker techniques that enable early-stage detection and monitoring, helping to slow disease progression and improve patient quality of life. Dr. Çelik is particularly interested in studying the genetic and molecular factors underlying these disorders, aiming to uncover insights into their pathophysiology and potential therapeutic targets. Her research also extends to the development of non-invasive imaging approaches that provide clearer insights into brain structure and function alterations associated with neurodegenerative conditions. Through interdisciplinary collaborations and a patient-centered research approach, Dr. Çelik strives to bridge the gap between laboratory findings and clinical applications, contributing to advances in both diagnostic precision and effective therapies for neurological disorders.
Awards and Honors
Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has earned numerous awards and honors in recognition of her contributions to neurodegenerative disease research. Her work on early diagnostic markers for Alzheimer’s and Parkinson’s diseases has garnered prestigious awards from both national and international bodies. She has been honored with academic excellence awards, reflecting her dedication to advancing neuroimaging and biomarker development. Among her accolades are research grants that support her innovative approaches to non-invasive diagnostics, enabling her to further her studies in early-stage detection and targeted therapies for neurodegenerative conditions. Dr. Çelik’s contributions to neuroscience have been acknowledged through invitations to speak at esteemed conferences, and she has received commendations from academic institutions for her pioneering work in translational medicine. Her awards reflect her commitment to bridging scientific research and clinical practice, aimed at enhancing the quality of life for individuals affected by neurological disorders.
Conclusion
Dr. Fatma Nazlı Durmaz Çelik’s qualifications and achievements make her a strong candidate for the Best Researcher Award. Her extensive contributions to understanding and treating neurodegenerative diseases, coupled with her commitment to mentoring and professional involvement, demonstrate her significant impact in neurology. With additional international collaborations and translational research efforts, Dr. Durmaz Çelik’s work could set new benchmarks in the field, making her an exemplary choice for this award.
Publications top noted📜
- Mitochondrial serine protease HTRA2 p. G399S in a kindred with essential tremor and Parkinson disease
Authors: H. Unal Gulsuner, S. Gulsuner, F.N. Mercan, O.E. Onat, T. Walsh, H. Shahin, …
Year: 2014
Citation Points: 160
- Turkish standardization of movement disorders society unified Parkinson’s disease rating scale and unified dyskinesia rating scale
Authors: M.C. Akbostanci, E. Bayram, V. Yilmaz, S. Rzayev, S. Özkan, A.B. Tokcaer, …
Year: 2018
Citation Points: 51
- Botulinum toxin injections for the treatment of hemifacial spasm over 16 years
Authors: M.H. Sorgun, R. Yilmaz, Y.A. Akin, F.N. Mercan, M.C. Akbostanci
Year: 2015
Citation Points: 51
- Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement
Authors: P.T. Kısa, G.K. Yildirim, B.O. Hismi, S. Dorum, O.Y. Kusbeci, A. Topak, F. Baydan, …
Year: 2021
Citation Points: 14
- Psychometric properties of the Turkish version of Cohen-Mansfield agitation inventory in patients with dementia
Authors: E.T. Özel-Kızıl, G. Baştuğ, Ş. Erdoğan, D. Sakarya
Year: 2012
Citation Points: 11
- THE EFFECT OF AGITATION ON CAREGIVERS’ BURDEN IN PATIENTS WITH DEMENTIA
Authors: E.T. Özel-Kızıl, H.Ö. Altintaş, G. Baştuğ, N. Durmaz, U. Altunöz
Year: 2014
Citation Points: 10
- No effect of different stimulation conditions on verbal fluency and visuospatial orientation in patients with subthalamic nucleus deep brain stimulation
Authors: R. Yilmaz, M.C. Akbostancı, F.N. Mercan, M.H. Sorgun, A. Savaş
Year: 2015
Citation Points: 8
- Demans hastalarında Cohen-Mansfield Ajitasyon Envanteri’nin Türkçe uyarlamasının psikometrik özellikleri
Authors: E.T. Kızıl Özel, G. Baştuğ, Ş. Erdoğan, D. Sakarya, N. Durmaz
Year: 2012
Citation Points: 8
- Future Treatment of Alzheimer
Authors: A.O. Keskin, N. Durmaz, G. Uncu, E. Erzurumluoğlu, Z. Yıldırım, N. Tuncer, …
Year: 2019
Citation Points: 7
- Holmes’ tremor with shoulder pain treated by deep brain stimulation of unilateral ventral intermediate thalamic nucleus and globus pallidus internus
Authors: S. Aydın, H. Canaz, E.T. Erdogan, N. Durmaz, B. Topcular
Year: 2017
Citation Points: 6
- A novel mutation in RNF216 gene in a Turkish case with Gordon Holmes syndrome
Authors: N. Durmaz Çelik, E. Erzurumluoğlu, S. Özben, U. Toprak, G. Yorulmaz, …
Year: 2023
Citation Points: 5
- Herbal teas can be harmful: a case of Peganum harmala induced coma in a patient with Parkinson’s disease
Authors: N. Durmaz Çelik, F. Ger Akarsu, S. Ozkan, A.Ö. Özdemir, Ö. Aykac, …
Year: 2021
Citation Points: 5
- Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
Authors: M. Kuzu Kumcu, S. Tezcan Aydemir, B. Ölmez, N. Durmaz Çelik, C. Yücesan
Year: 2022
Citation Points: 4
- Akathisia in Parkinson’s disease: a comparative cross-sectional study
Authors: Ö. Aykaç, F.N.D. Çelik, R. Yılmaz, E. Bayram, M.C. Akbostancı, Ş.O. Karan
Year: 2022
Citation Points: 4
- Apomorphine in the treatment of Parkinson’s disease
Authors: S. Özkan, S. Erer, B. Elibol, S. Özkaynak, R. Çakmur, M. Akbostancı, …
Year: 2021
Citation Points: 3
